Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Operative Stellate Ganglion Block for POAF Prevention
NCT05656170Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial in Atrial fibrillation (AFib) comparing Stellate ganglion block arm with Placebo arm (2 arms). Primary endpoint: Incidence of new onset atrial fibrillation after CABG surgery up to 1 month. Planned start Oct 2023; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05656170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05656170.